Five Pittsburgh scientists have received more than $1 million each to further their innovative work in biomedical science, many using new tools to understand the human body.
The largest amount went to neurobiologist Peter Strick, founding scientific director of the University of Pittsburgh Brain Institute, who was given $6 million by the National Institutes of Health and $5 million by the DSF Charitable Foundation to increase the scale of techniques used to map neural networks.
The $6 million NIH High-Risk, High-Reward research grant supports a project to establish a structural framework for the brain-body connection, discovering neural pathways that start in specific areas of the brain and affect immune function in the heart, digestive system and organs.
The DSF award supports related work at the Brain Institute that will explore changes in the brain pathways after exposure to nicotine, alcohol and other substances.
“The Brain Atlas initiative promises to achieve our shared goals of advancing the science and improving the diagnosis and treatment of devastating diseases and medical conditions,” said David N. Scaife, chairman of the family charitable foundation.
Both projects study brain networks by tracking the rabies virus as it moves from neuron to neuron, Mr. Strick explained.
Read More
“It allows us to reveal not just where something is going,” but as in a bus route, each stop or connection. The research goal is to map all the routes and how experience can change them.
“Some experiments will look at animals who have been exposed to drugs that are addictive,” the scientist said. “Does this change the brain fundamentally? We have clues that this is the case, that someone has been addicted, then is off drugs, but then relapse is easier for them.”
Mr. Strick said the brain has many networks. “What the Scaife funds are letting us do is develop all the tools to study one network. But we’re developing tools that are generalizable, that can be applied across the board.”
The NIH-funded research aims to understand psychosomatic diseases (involving both the mind and the body), which Mr. Strick said may account for about 30 percent of diseases that are medically unexplained.
“In the past, they were told this is all in your head. By the end of our study, I hope people are never told that. Your brain is in your head. The disorders are real.”
The rabies virus is used as a tracer because it “moves in reverse direction of neural impulses,” Mr. Strick said. From an organ of the body, it’s followed on its path to the brain. The monkeys used in the research do not suffer the symptoms of rabies, he noted.
Mr. Strick said earlier research had found, for example, that mindful meditation and core-strengthening exercises can steer regions of the brain away from stressful thoughts. “The way we move, the way we think, the way we feel, can have a profound influence on our organs.”
Computational scientist Partha Mitra at Cold Spring Harbor Lab in New York is also part of the NIH project and lends his expertise in whole brain analysis, Mr. Strick added.
In the other NIH awards, four local investigators were given an NIH Director’s New Innovator Award of $1.5 million to be used for their projects. They are:
• Warren Ruder, an assistant professor in Pitt’s department of bioengineering. His research group works at the interface of biology and engineering to create new biomimetic systems that provide insight into biological phenomena and serve as platform technologies for future medical applications. The award-winning project is working on the development of engineered cells that can be activated by high magnetic field gradients.
• Erik Wright, an assistant professor of biomedical informatics at Pitt. His lab focuses on antibiotic resistance. The project explores using the power of microbial genomes to discover new antibiotics and find better ways of prescribing them.
• Kathryn A. Whitehead, an assistant professor in the chemical engineering and biomedical engineering departments at Carnegie Mellon University. Her lab develops RNA and protein drug delivery systems. The project aims to develop a system to non-invasively deliver protein drugs and cellular therapy to infants through genetically engineered breast milk cells.
• Yongxin “Leon” Zhao, an assistant professor in CMU’s department of biological sciences. He plans to use the NIH funding to develop more powerful imaging platforms to magnify biopsies at the nanoscale. It will build on his new technique called Expansion Pathology, which uses existing microscopy equipment to directly observe subtle pathological changes in diseased tissues and add to the understanding of biomolecules in complex diseases.
Jill Daly: jdaly@post-gazette.com.





Comments
Welcome to Post-Gazette subscriber-only commenting community. Please review our community guidelines.